Iowa Mesothelioma Fact Sheet
While mesothelioma is a problem in all states, the specific incident rate for Iowa is 0.8 / 100,000. This is below the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in IA, recent IA mesothelioma-related court cases, mesothelioma specialists in IA and potential asbestos hotspots in Iowa.
Iowa Mesothelioma Info
By clicking on the above tabs, you will find information on mesothelioma specific to the state of Iowa
Iowa Research and Clinical Trials
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Iowa Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Iowa Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Iowa Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Iowa Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
Hospitals and Cancer Centers
| City | Site |
| Joliet |
Northern Petro Chemical |
| Little Sioux |
Shearer Contractors |
| Mason City |
Northwestern States Portland Cement |
| Waterloo |
Iowa Power Plant |
Research
Donham, Kelley J. The Pathogenesis Of Asbestos Related Bowel Cancer
Grant: 1R26CA016762-01
Grant: 1R26CA016762-01
Abstract: Workers exposed to asbestos have an increased incidence of bowel cancer as well
as an increased incidence of lung cancer and mesothelioma. A pathologic study
of a sample of asbestos-related bowel cancers revealed a very unusual type of
chronic colitis underlying and apparently preceding the cancer. The proposal is
to study asbestos cancers and precursor lesions in detail. Human material will
be reviewed. In addition, the intestines of rats fed asbestos will be studied
in detail to determine the full range and time sequence of asbestos-related
pathology. Following this, the asbestos lesions will be studied as possible
preferential sites for induction by known bowel carcinogens.
Tags: Diseases, Pathologic Processes (not Classified Elsewhere), Gastrointestinal Neoplasms, Colon Growths, Neoplasms Of Gastrointestinal System, Colon Growths, Neoplastic Transformation, Carcinogens, Neoplastic Transformation, Carcinogens (general), Silicates, Asbestos Gastrointestinal Disorders, Enteritis, Colitis Human, Non-clinical, Human, Nonclinical*, Mammals, Rats*
Tags: Diseases, Pathologic Processes (not Classified Elsewhere), Gastrointestinal Neoplasms, Colon Growths, Neoplasms Of Gastrointestinal System, Colon Growths, Neoplastic Transformation, Carcinogens, Neoplastic Transformation, Carcinogens (general), Silicates, Asbestos Gastrointestinal Disorders, Enteritis, Colitis Human, Non-clinical, Human, Nonclinical*, Mammals, Rats*
- Followup Grant: 5R26CA016762-02
- Followup Grant: 5R26CA016762-03
- Followup Grant: 2R26CA016762-04
Clinical Trials
Condition: Malignant Mesothelioma
Intervention: Drug: carboplatin; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium
More Information
Intervention: Drug: carboplatin; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium
More Information
Condition: Malignant Mesothelioma
Intervention: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis
More Information
Intervention: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis
More Information
Condition: Malignant Mesothelioma
Intervention: Drug: epirubicin hydrochloride; Drug: gemcitabine hydrochloride
More Information
Intervention: Drug: epirubicin hydrochloride; Drug: gemcitabine hydrochloride
More Information
